Tumor size and clinical outcomes in melanoma patients (MEL pts) treated with talimogene laherparepvec (T-VEC).
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Rutgers Cancer Institute, Mary Crowley Cancer Research Center, University of Louisville, Emory University, Northern California Melanoma Center, University of North Carolina at Chapel Hill, The University of Texas MD Anderson Cancer Center, Amgen (United States), Huntsman Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2433758173
